Crestchem Ltd. Announces Financial Results for FY 2026; Recommends Dividend and Confirms Subsidiary Investment

Crestchem Ltd. Announces Financial Results for FY 2026; Recommends Dividend and Confirms Subsidiary Investment​

Crestchem Ltd. has announced the outcome of its Board of Directors meeting, detailing its Standalone and Consolidated Audited Financial Results for the quarter and year ended March 31, 2026. The board meeting also included the recommendation of a final dividend and major approvals related to corporate structure and management appointments.

Financial Results Summary​

The company reported significant growth across its financials for the year ending March 31, 2026. The audited results show the following key figures for the quarter and the full fiscal year.

The table below outlines the Standalone and Consolidated Financial Results for Crestchem Ltd. (figures are in Rs. in Lacs).


The consolidated financial results report a Total Income of 1,042.91 in the quarter ended March 31, 2026, rising to 3,026.62 for the full year. The total comprehensive income for the period was 270.96, reaching 271.35 for the year.

Key Corporate and Investment Approvals​

During the board meeting, the directors approved several strategic and operational decisions:

Dividend Recommendation:
The board recommended a final dividend of Rs. 1.50 per Equity Share of Rs. 10/- each (15%) for the financial year 2025-26. This recommendation is subject to the approval of the shareholders at the Annual General Meeting.

Subsidiary Formation and Investment:
The board took note of the formation of a new subsidiary company, OLEO BIOSCIENCES PRIVATE LIMITED, in Bangalore, Karnataka. This subsidiary was incorporated on March 31, 2026, and has not commenced commercial operations during the financial year 2026. The board approved investing within the subsidiary OLEO BIOSCIENCES PRIVATE LIMITED, with the investment limit not exceeding Rs. 2.25 Crores, which can be executed via loan, intercorporate loans, or Equity Share Capital.

Management and Operational Updates​

The board also approved reappointment and remuneration for three key personnel:

• Mr. Dipak Narendraprasad Patel: Approved for a period of five years, from October 1, 2026, to September 30, 2031.
• Mrs. Parul Dipak Patel: Approved for a period of five years, from October 1, 2026, to September 30, 2031, under Section 188 of the Companies Act, 2013.
• Mrs. Tansi Nirmit Patel: Approved for a period of five years, from April 1, 2026, to March 31, 2031, under Section 188 of the Companies Act, 2013.

Furthermore, the company approved the filing of the audited standalone and consolidated financial results, confirming the performance for the quarter and year ended March 31, 2026. The company stated that the subsidiary, Oleo Biosciences Private Limited, has not conducted any significant financial transactions during the financial year, other than recognizing subscription money receivable/payable in the respective financial statements.

Balance Sheet Snapshot​

Comparing the Balance Sheet data, the total assets of Crestchem Ltd. increased significantly year-over-year.


The consolidated balance sheet figures also show total assets rising to 1,623.92 Rs in Lacs as of March 31, 2026, compared to 1,054.48 Rs in Lacs on the same date the previous year.

***
Note: All financial figures are reported in Rs. in Lacs, based on audited data.

Stock Price Movement​

As of 12:10, Crestchem Ltd shares are ticking up to ₹135.00, climbing 8.87% in today's trading. The stock has demonstrated significant intraday movement, dipping to a low of ₹128.00 before reaching a high of ₹137.85.